Order results by:
Issue | Title | |
Vol 14, No 2 (2021) | Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region | Abstract similar documents |
A. D. Ermolaeva, V. S. Krysanova, T. N. Ermolaeva, K. I. Polyakova, K. A. Kokushkin | ||
"... of subgroups selection in the structure of basic DRG No. 336 st36.003 and No. 139 ds36.004 “Treatment ..." | ||
Vol 13, No 3 (2020) | The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups | Abstract similar documents |
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan | ||
"... that would exceed an average payment rate for DRG st36.003 and ds36.004 in 2020. In the model, an increase ..." | ||
Vol 12, No 3 (2019) | Diagnosis-related groups and payments for the treatment of malignant neoplasms in the model of 2019 | Abstract similar documents |
D. V. Fedyaev , V. V. Omelyanovskiy , M. L. Lazareva , Yu. V. Seryapina, Yu. A. Ledovskikh | ||
"... The article addresses the model of diagnosis-related groups (DRG) updated according to the new ..." | ||
Vol 16, No 2 (2023) | Methodological approach to the formation of the list of high-tech medical care types | Abstract similar documents |
I. A. Zheleznyakova, O. A. Volkova, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, Yu. S. Zueva, I. A. Alexandrov, V. V. Omelyanovskiy | ||
"... groups (DRGs), on the one hand, significantly expanded the availability of HTMC methods ..." | ||
Vol 16, No 2 (2023) | Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 | Abstract similar documents |
V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova | ||
"... -related groups (DRG) with the use of interferon-containing drugs as etiotropic therapy, which has been ..." | ||
Vol 11, No 2 (2018) | Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations | Abstract similar documents |
M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov | ||
"... терапию ГИБП. Предложенные в субъектах РФ модели разукрупнения КСГ для назначения ГИБП после экспертной ..." | ||
Vol 13, No 3 (2020) | The review of the foreign experience on the financing of innovative medical technologies | Abstract similar documents |
V. V. Omelyanovskiy, I. A. Zheleznyakova, T. P. Bezdenezhnykh, M. L. Lazareva, D. V. Fedyaev | ||
"... -related groups (DRG) does not contribute to the implementation of innovations in the medical practice ..." | ||
Vol 15, No 1 (2022) | Efficacy of targeted drugs for the treatment of adults with moderate-to-severe plaque psoriasis in the Russian Federation: a systematic literature review update | Abstract similar documents |
V. D. Sokolova, N. A. Sableva, V. V. Mladov, D. G. Tolkacheva | ||
Vol 10, No 4 (2017) | THE STATE GUARANTEES PROGRAM OF FREE MEDICAL CARE: APPROACHES TO STANDARDIZE THE COSTS OF MEDICAL CARE | Abstract similar documents |
Yu. A. Ledovskikh, E. V. Semakova, M. V. Avksent’eva | ||
Vol 14, No 2 (2021) | Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting | Abstract similar documents |
E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov | ||
"... (DRG), except for cases with a maximum duration in a day hospital setting. An analysis of the RDC lists ..." | ||
Vol 9, No 1 (2016) | REVIEW OF HEALTH SYSTEM ORGANIZATION APPROACHES TO ESTIMATING SERVICE LEVELS AND EXPENDITURES FOR INPATIENT CARE SERVICES | Abstract similar documents |
K. V. Gerasimova, D. V. Fedyaev, M. V. Sura, A. A. Tikhonova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
"... is based on per case of treatment for a relevant group of diseases (diagnosis related group (DRG ..." | ||
Vol 16, No 4 (2023) | Analysis of the clinical and economic effectiveness of using benralizumab in comparison with standard therapy in patients with severe bronchial asthma | Abstract similar documents |
S. V. Nedogoda, A. S. Salasyuk, S. N. Avdeev, I. N. Barykina, V. O. Lutova, E. A. Popova | ||
"... стандартной терапией у пациентов с тяжелой бронхиальной астмой (ТБА) с эозинофильным фенотипом в Российской ..." | ||
Vol 15, No 2 (2022) | Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings | Abstract similar documents |
M. V. Zhuravleva, S. N. Avdeev, Yu. V. Gagarina, T. V. Marin | ||
"... круглосуточного стационара для лечения тяжелой бронхиальной астмы (ТБА). Материал и методы. Использовали методы ..." | ||
Vol 9, No 1 (2016) | PHARMACOECONOMIC SUBSTANTIATION OF APPLICATION OF GENETICALLY ENGINEERED BIOLOGICAL AGENTS IN OUT-PATIENT CONDITIONS | Abstract similar documents |
O. Yu. Korennova, L. V. Shukil', S. N. Mal'tsev, I. A. Klinyshkov, N. M. Leganova, E. A. Turusheva, T. V. Kropotina | ||
"... пациентов с ревматическими заболеваниями (РЗ) генно-инженерными биологическими препаратами (ГИБП) в условиях ..." | ||
Vol 14, No 2 (2021) | Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis | Abstract similar documents |
A. V. Rudakova, D. G. Tolkacheva, V. D. Sokolova | ||
"... препаратами (ГИБП) и таргетными синтетическими базисными противовоспалительными препаратами (тсБПВП) и оценка ..." | ||
Vol 9, No 3 (2016) | HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE | Abstract similar documents |
A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina | ||
"... ГИБП – адалимумабом и инфликсимабом. Заключение. Выбор в пользу этанерцепта или тофацитиниба, учитывая ..." | ||
Vol 12, No 4 (2019) | Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation | Abstract similar documents |
S. K. Zyryanov, I. N. Diyakov, S. N. Avdeev | ||
"... пациентов с бронхиальной астмой, получающих генно-инженерные биологические препараты (ГИБП), переключение ..." | ||
1 - 17 of 17 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)